Literature DB >> 29770957

First-in-Rat Study of Human Alzheimer's Disease Tau Propagation.

Tomas Smolek1,2, Santosh Jadhav1,2, Veronika Brezovakova1, Veronika Cubinkova1,2, Bernadeta Valachova1, Petr Novak1,3, Norbert Zilka4,5.   

Abstract

One of the key features of misfolded tau in human neurodegenerative disorders is its propagation from one brain area into many others. In the last decade, in vivo tau spreading has been replicated in several mouse transgenic models expressing mutated human tau as well as in normal non-transgenic mice. In this study, we demonstrate for the first time that insoluble tau isolated from human AD brain induces full-blown neurofibrillary pathology in a sporadic rat model of tauopathy expressing non-mutated truncated tau protein. By using specific monoclonal antibodies, we were able to monitor the spreading of tau isolated from human brain directly in the rat hippocampus. We found that exogenous human AD tau was able to spread from the area of injection and induce tau pathology. Interestingly, solubilisation of insoluble AD tau completely abolished the capability of tau protein to induce and spread of neurofibrillary pathology in the rat brain. Our results show that exogenous tau is able to induce and drive neurofibrillary pathology in rat model for human tauopathy in a similar way as it was described in various mouse transgenic models. Rat tau spreading model has many advantages over mouse and other organisms including size and complexity, and thus is highly suitable for identification of pathogenic mechanism of tau spreading.

Entities:  

Keywords:  Alzheimer’s disease; Neurofibrillary tangles; Prion-like spreading; Tau spreading; Tau strains

Mesh:

Substances:

Year:  2018        PMID: 29770957     DOI: 10.1007/s12035-018-1102-0

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  52 in total

1.  The complex relationship between soluble and insoluble tau in tauopathies revealed by efficient dephosphorylation and specific antibodies.

Authors:  D P Hanger; G M Gibb; R de Silva; A Boutajangout; J-P Brion; T Revesz; A J Lees; B H Anderton
Journal:  FEBS Lett       Date:  2002-11-20       Impact factor: 4.124

2.  First insert of tau protein is present in all stages of tau pathology in Alzheimer's disease.

Authors:  Katarina Soltys; Gabriela Rolkova; Lubica Vechterova; Peter Filipcik; Norbert Zilka; Eva Kontsekova; Michal Novak
Journal:  Neuroreport       Date:  2005-10-17       Impact factor: 1.837

3.  Attenuated hippocampus-dependent learning and memory decline in transgenic TgAPPswe Fischer-344 rats.

Authors:  Nelson Ruiz-Opazo; Kenneth S Kosik; Lyle V Lopez; Pia Bagamasbad; Lorenz Rb Ponce; Victoria Lm Herrera
Journal:  Mol Med       Date:  2004 Jan-Jun       Impact factor: 6.354

Review 4.  Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau.

Authors:  D R Williams
Journal:  Intern Med J       Date:  2006-10       Impact factor: 2.048

5.  Overexpression of APP provides neuroprotection in the absence of functional benefit following middle cerebral artery occlusion in rats.

Authors:  Jared Clarke; Anders Thornell; Dale Corbett; Hilkka Soininen; Mikko Hiltunen; Jukka Jolkkonen
Journal:  Eur J Neurosci       Date:  2007-10       Impact factor: 3.386

6.  Rat transgenic models with a phenotype of intracellular Abeta accumulation in hippocampus and cortex.

Authors:  Valentina Echeverria; Adriana Ducatenzeiler; Leena Alhonen; Juhani Janne; Susan M Grant; Francisco Wandosell; Andres Muro; Francisco Baralle; Hongshan Li; Karen Duff; Moshe Szyf; A Claudio Cuello
Journal:  J Alzheimers Dis       Date:  2004-06       Impact factor: 4.472

Review 7.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

8.  Determining stability of proteins from guanidinium chloride transition curves.

Authors:  F Ahmad; S Yadav; S Taneja
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

9.  A transgenic rat expressing human APP with the Swedish Alzheimer's disease mutation.

Authors:  Ronnie Folkesson; Katarzyna Malkiewicz; Ewa Kloskowska; Tatjana Nilsson; Elena Popova; Nenad Bogdanovic; Ursula Ganten; Detlev Ganten; Michael Bader; Bengt Winblad; Eirikur Benedikz
Journal:  Biochem Biophys Res Commun       Date:  2007-05-08       Impact factor: 3.575

10.  Interactions between hydrophobic and ionic solutes in aqueous guanidinium chloride and urea solutions: lessons for protein denaturation mechanism.

Authors:  Edward P O'Brien; Ruxandra I Dima; Bernard Brooks; D Thirumalai
Journal:  J Am Chem Soc       Date:  2007-05-16       Impact factor: 15.419

View more
  4 in total

1.  Role of Microglial Cells in Alzheimer's Disease Tau Propagation.

Authors:  Ena Španić; Lea Langer Horvat; Patrick R Hof; Goran Šimić
Journal:  Front Aging Neurosci       Date:  2019-10-04       Impact factor: 5.750

2.  Genetic Background Influences the Propagation of Tau Pathology in Transgenic Rodent Models of Tauopathy.

Authors:  Tomas Smolek; Veronika Cubinkova; Veronika Brezovakova; Bernadeta Valachova; Peter Szalay; Norbert Zilka; Santosh Jadhav
Journal:  Front Aging Neurosci       Date:  2019-12-11       Impact factor: 5.750

3.  Enriched environment ameliorates propagation of tau pathology and improves cognition in rat model of tauopathy.

Authors:  Veronika Mate; Tomas Smolek; Zuzana Vince Kazmerova; Santosh Jadhav; Veronika Brezovakova; Bernadeta Jurkanin; Ivana Uhrinova; Neha Basheer; Norbert Zilka; Stanislav Katina; Petr Novak
Journal:  Front Aging Neurosci       Date:  2022-07-26       Impact factor: 5.702

Review 4.  Tau Seeding Mouse Models with Patient Brain-Derived Aggregates.

Authors:  Aiko Robert; Michael Schöll; Thomas Vogels
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.